Skip to content
Last run passedcali
UTC--:--:--

← startups

DropGenie

dropgenie.com ↗ · Montréal and Boston · $5 million USD

via betakit.com · Oct 26
93/100seedqualified

A microfluidic chip that performs gene editing on tiny droplets, enabling high‑throughput biological screening with 100× less sample and reagent volume.

  • digital microfluidics
  • microfluidic chip
  • automation systems

bottleneck › Scaling the automated lab workflow software and integrating real‑time data pipelines across the microfluidic hardware.

contact

✉ hello@drop-genie.com generalsource

✉ hello@dropgenie.com generalsource

contact page ↗

pitch

You can replace the custom data‑pipeline glue with a Next.js front‑end that pulls experiment metadata into a vector‑semantic search index, letting scientists instantly query results across thousands of tiny‑drop runs. This eliminates the manual stitching of hardware logs and speeds up downstream analysis for your automation platform.

email draft › hello@drop-genie.com

intent: build for them (a concrete bottleneck on a stack you can work with)

DropGenie: a thought on Scaling the automated lab workflow software and integrating

Hi Alison,

Congrats on the new funding (https://betakit.com/dropgenie-raises-5-million-usd-backed-by-bdc-to-speed-up-biological-discovery/).

I came across DropGenie: A microfluidic chip that performs gene editing on tiny droplets, enabling high‑throughput biological screening with 100× less sample and.
One thing I noticed: scaling the automated lab workflow software and integrating real‑time data pipelines across the microfluidic hardware.

You can replace the custom data‑pipeline glue with a Next.js front‑end that pulls experiment metadata into a vector‑semantic search index, letting scientists instantly query results across thousands of tiny‑drop runs.

Would a short trial project to tackle this be useful?

If this isn't relevant, just reply "no" and I won't follow up.
address published on this page ↗
Open in mail

signals

qualification

  • fit10000%
  • reach10000%
  • evidence10000%

timeline

  1. Oct 26 found · Stage: seed-plus · Raised: $5 million USD · HQ: Montréal and Boston · +23 moresource
  2. Oct 26 learned · Person: Lead Investor · Person: Investorsource
  3. Oct 26 funding · Fundingsource

similar companies

score › fit 25/25 · identity 15/15 · people 20/20 · connections 20/20 · contact 13/20

missing › phone

people

  • Alison Hirukawa · CEO & Co‑founder
    “CEO Alison Hirukawa met her co‑founders...”
  • Hugo Sinha · Co‑founder in
    “met Hugo Sinha... through a McGill‑associated research project”
  • Mathieu Husser · Co‑founder (former)
    “Mathieu Husser (who is no longer with the company)”

connections

  • Alison Hirukawa founded DropGenie
    “CEO Alison Hirukawa met her co‑founders...”
  • Hugo Sinha cofounded DropGenie
    “met Hugo Sinha... through a McGill‑associated research project”
  • Mathieu Husser cofounded DropGenie
    “Mathieu Husser (who is no longer with the company)”
  • BDC Capital’s Thrive Fund invested in DropGenie
    “BDC Capital’s Thrive Fund as a new investor for its seed‑plus financing”
  • Skeleton Key invested in DropGenie
    “Massachusetts‑based Skeleton Key had led that financing”
  • Merck Global Health Innovation Fund invested in DropGenie
    “alongside Merck Global Health Innovation Fund”
  • CQDM invested in DropGenie
    “alongside ... CQDM”
  • Real Ventures invested in DropGenie
    “with participation from Montréal’s Real Ventures”
  • Anges Québec invested in DropGenie
    “with participation from ... Anges Québec”
  • AbbVie customer of DropGenie
    “partnerships with AbbVie, UCB Pharma”
  • UCB Pharma customer of DropGenie
    “partnerships with AbbVie, UCB Pharma”
  • Danaher customer of DropGenie
    “life science instrument companies like Danaher and Sartorius”
  • Sartorius customer of DropGenie
    “life science instrument companies like Danaher and Sartorius”

Trackbacks

Company

  • core_product: A microfluidic chip that performs gene editing on tiny droplets, enabling high‑throughput biological screening with 100× less sample and reagent volume. inferred · first seen Oct 26, last Oct 29
  • funding_amount: $5 million USD inferred · first seen Oct 26, last Oct 29
  • funding_stage: seed-plus inferred · first seen Oct 26, last Oct 29
  • hq: Montréal and Boston inferred · first seen Oct 26, last Oct 29
  • likely_bottleneck: Scaling the automated lab workflow software and integrating real‑time data pipelines across the microfluidic hardware. inferred · first seen Oct 26, last Oct 29
  • website: https://dropgenie.com inferred · first seen Oct 29

People

  • Alison Hirukawa · CEO & Co‑founder verified · first seen Oct 26, last Oct 29
    “CEO Alison Hirukawa met her co‑founders...”
  • Hugo Sinha · Co‑founder verified · first seen Oct 26, last Oct 29
    “met Hugo Sinha... through a McGill‑associated research project”
  • Hugo Sinha · linkedin matched · first seen Oct 26, last Oct 29
    “met Hugo Sinha... through a McGill‑associated research project”
  • Mathieu Husser · Co‑founder (former) verified · first seen Oct 26, last Oct 29
    “Mathieu Husser (who is no longer with the company)”
  • Anges Québec · Investor verified · first seen Oct 26
    “with participation from ... Anges Québec”
  • Skeleton Key · Lead Investor verified · first seen Oct 26
    “Massachusetts‑based Skeleton Key had led that financing”

Connections

  • AbbVie customer of DropGenie verified · first seen Oct 26, last Oct 29
    “partnerships with AbbVie, UCB Pharma”
  • Alison Hirukawa founded DropGenie verified · first seen Oct 26, last Oct 29
    “CEO Alison Hirukawa met her co‑founders...”
  • Alison Hirukawa previously at McGill University’s Goodman Cancer Research Centre verified · first seen Oct 26, last Oct 29
    “Hirukawa, who was a postdoctoral fellow at McGill University’s Goodman Cancer Research Centre”
  • Anges Québec invested in DropGenie verified · first seen Oct 26, last Oct 29
    “with participation from ... Anges Québec”
  • BDC Capital’s Thrive Fund invested in DropGenie verified · first seen Oct 26, last Oct 29
    “BDC Capital’s Thrive Fund as a new investor for its seed‑plus financing”
  • CQDM invested in DropGenie verified · first seen Oct 26, last Oct 29
    “alongside ... CQDM”
  • Danaher customer of DropGenie verified · first seen Oct 26, last Oct 29
    “life science instrument companies like Danaher and Sartorius”
  • Hugo Sinha cofounded DropGenie verified · first seen Oct 26, last Oct 29
    “met Hugo Sinha... through a McGill‑associated research project”
  • Mathieu Husser cofounded DropGenie verified · first seen Oct 26, last Oct 29
    “Mathieu Husser (who is no longer with the company)”
  • Merck Global Health Innovation Fund invested in DropGenie verified · first seen Oct 26, last Oct 29
    “alongside Merck Global Health Innovation Fund”
  • Real Ventures invested in DropGenie verified · first seen Oct 26, last Oct 29
    “with participation from Montréal’s Real Ventures”
  • Sartorius customer of DropGenie verified · first seen Oct 26, last Oct 29
    “life science instrument companies like Danaher and Sartorius”
  • Skeleton Key invested in DropGenie verified · first seen Oct 26, last Oct 29
    “Massachusetts‑based Skeleton Key had led that financing”
  • UCB Pharma customer of DropGenie verified · first seen Oct 26, last Oct 29
    “partnerships with AbbVie, UCB Pharma”

Contact

  • email: hello@drop-genie.com verified · first seen Oct 29
  • email: hello@dropgenie.com verified · first seen Oct 29